|
|
||||||||
Department of Microbiology and Immunology and Sealy Center for Molecular Science, University of Texas Medical Branch, Galveston, TX 77555
Regulation of homeostasis in the immune system includes mechanisms that promote survival of resting T lymphocytes, and others that control activation-induced cell death (AICD). In this study, we report on the use of a transgenic mouse model to test the role of CD4-MHC class II interactions for the susceptibility of CD4+ T lymphocytes to AICD, and for the survival of resting CD4+ T cells in peripheral lymphoid organs. The only I-Aß gene expressed in these mice is an Aßk transgene with a mutation that prevents MHC class II molecules from interacting with CD4. We show increased apoptosis in CD4+ T lymphocytes derived from wild-type, but not from mutant Aßk transgenic mice following stimulation with staphylococcal enterotoxin A. Therefore, AICD may be impaired in CD4+ T cells derived from mutant Aßk transgenic mice. Importantly, we observed much higher apoptosis in resting CD4+ T cells from mutant Aßk transgenic mice than from wild-type mice. Furthermore, resting CD4+ T cells from mutant Aßk transgenic mice expressed higher levels of cell surface CD95 (Fas, APO-1). Ab-mediated cross-linking of CD95 further increased apoptosis in CD4+ T cells from mutant Aßk transgenic mice, but not from wild-type mice, suggesting apoptosis involved CD95 signaling. When cocultured with APC-expressing wild-type MHC class II molecules, apoptosis in resting CD4+ T lymphocytes from mutant Aßk transgenic mice was reduced. Our results show for the first time that interactions between CD4 and MHC class II molecules are required for the survival of resting CD4+ T cells in peripheral lymphoid organs.
This article has been cited by other articles:
![]() |
Z. Tatari-Calderone, J. L. Brogdon, K. W. Tinsley, A. Ramezani, and D. Leitenberg CD4-Dependent Signaling Is Required for a Late Checkpoint during Th2 Development Associated with Resistance to Activation-Induced Cell Death J. Immunol., November 1, 2005; 175(9): 5629 - 5636. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stoicov, X. Cai, H. Li, K. Klucevsek, J. Carlson, R. Saffari, and J. Houghton Major Histocompatibility Complex Class II Inhibits Fas Antigen-Mediated Gastric Mucosal Cell Apoptosis through Actin-Dependent Inhibition of Receptor Aggregation Infect. Immun., October 1, 2005; 73(10): 6311 - 6321. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Wolkersdorfer, C. Marx, J. Brown, S. Schroder, M. Fussel, E. P. Rieber, E. Kuhlisch, G. Ehninger, and S. R. Bornstein Prevalence of HLA-DRB1 Genotype and Altered Fas/Fas Ligand Expression in Adrenocortical Carcinoma J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1768 - 1774. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, J. Strong, and N. Killeen Homeostatic Competition Among T Cells Revealed by Conditional Inactivation of the Mouse Cd4 Gene J. Exp. Med., December 10, 2001; 194(12): 1721 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Wang, L. Malherbe, D. Zhang, K. Zingler, N. Glaichenhaus, and N. Killeen CD4 Promotes Breadth in the TCR Repertoire J. Immunol., October 15, 2001; 167(8): 4311 - 4320. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Strong, Q. Wang, and N. Killeen Impaired survival of T helper cells in the absence of CD4 PNAS, February 27, 2001; 98(5): 2566 - 2571. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |